[{"data":1,"prerenderedAt":24},["ShallowReactive",2],{"$f2ThdRBQ5taT2ySx2SoDrhJ4V0xN7leKCG2QW-zOoKsY":3},{"card":4,"examId":6,"chapterTitle":21,"prev":22,"next":23},{"id":5,"examId":6,"prompt":7,"answer":8,"choices":9,"questionType":12,"explanation":13,"explanationDetail":14,"mistakeHint":15,"lectureRef":14,"storyRef":14,"chapterSlug":16,"sectionCode":17,"sectionTitle":18,"clusterSlug":19,"term":14,"sequenceOrder":14,"regionWeight":14,"revisionMark":14,"isActive":20},"ch5-046","touhan","副作用等の報告で、医薬品との因果関係が明確でない場合は報告対象とならない。",1,[10,11],"正しい","誤り","ox","因果関係が必ずしも明確でない場合であっても、報告の対象となり得ます。過量使用や誤用等によるものと考えられる健康被害も、必要に応じて報告対象となります。",null,"「因果関係が明確でなければ報告不要」は誤りです。疑われる段階でも報告する姿勢が求められます。ここは試験でよく狙われます。","chapter-5","5-II-2","副作用情報等の評価及び措置","fukusayou-hyouka",true,"第5章 医薬品の適正使用・安全対策","ch5-045","ch5-047",1784619074271]